Please use this identifier to cite or link to this item:
Title: Tumor-targeted Chlorotoxin-coupled Nanoparticles for Nucleic Acid Delivery to Glioblastoma Cells: A Promising System for Glioblastoma Treatment
Authors: Costa, Pedro M. 
Cardoso, Ana L. 
Mendonça, Liliana S. 
Serani, Angelo 
Custódia, Carlos 
Conceição, Mariana 
Simões, Sérgio 
Moreira, João N. 
Almeida, Luis Pereira de 
Lima, M. C. P. de 
Keywords: chlorotoxin; glioblastoma; liposome; miR-21; stable nucleic acid lipid particle
Issue Date: 2013
Publisher: The American Society of Gene & Cell Therapy
Serial title, monograph or event: Molecular Therapy—Nucleic Acids
Volume: 2
Issue: Artigo e100
Abstract: The present work aimed at the development and application of a lipid-based nanocarrier for targeted delivery of nucleic acids to glioblastoma (GBM). For this purpose, chlorotoxin (CTX), a peptide reported to bind selectively to glioma cells while showing no affinity for non-neoplastic cells, was covalently coupled to liposomes encapsulating antisense oligonucleotides (asOs) or small interfering RNAs (siRNAs). The resulting targeted nanoparticles, designated CTX-coupled stable nucleic acid lipid particles (SNALPs), exhibited excellent features for in vivo application, namely small size (<180 nm) and neutral surface charge. Cellular association and internalization studies revealed that attachment of CTX onto the liposomal surface enhanced particle internalization into glioma cells, whereas no significant internalization was observed in noncancer cells. Moreover, nanoparticle-mediated miR-21 silencing in U87 human GBM and GL261 mouse glioma cells resulted in increased levels of the tumor suppressors PTEN and PDCD4, caspase 3/7 activation and decreased tumor cell proliferation. Preliminary in vivo studies revealed that CTX enhances particle internalization into established intracranial tumors. Overall, our results indicate that the developed targeted nanoparticles represent a valuable tool for targeted nucleic acid delivery to cancer cells. Combined with a drug-based therapy, nanoparticle-mediated miR-21 silencing constitutes a promising multimodal therapeutic approach towards GBM.
DOI: 10.1038/mtna.2013.30
Rights: openAccess
Appears in Collections:FCTUC Ciências da Vida - Artigos em Revistas Internacionais

Files in This Item:
File Description SizeFormat
mtna201330a(1).pdf3.99 MBAdobe PDFView/Open
Show full item record


checked on Nov 11, 2022

Citations 1

checked on Aug 2, 2022

Page view(s) 50

checked on Nov 21, 2022

Download(s) 50

checked on Nov 21, 2022

Google ScholarTM




Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.